Notice of Extraordinary Meeting of Gambro AB, June 21, 2006
June 05, 2006
In accordance with the listing agreement with Stockholmsbörsen AB (the Stockholm Stock Exchange), Gambro AB hereby also announces, by issuing a press release, the content of the notice concerning Gambro’s extraordinary shareholders’ meeting.
Attachment: Notice of Gambro’s Extraordinary Shareholders’ Meeting.
For further information please contact: Paula Treutiger, Vice President, Corporate Communications, tel. +46-8-613 65 99, +46-73-366 65 99 Sophie Monsén, Manager, Investor Relations, Corporate Finance, tel. +46-8-613 65 02, +46-73-366 65 02
Gambro is a global medical technology company with related services and has leading positions in renal care - services and products - and blood component technology. Gambro Renal Products develops and supplies hemodialysis, peritoneal dialysis, and acute renal and liver dialysis products, therapies and services. Gambro Healthcare is a provider of end-stage renal disease treatment and patient care. Gambro BCT develops and provides blood collection, apheresis and cell therapy products and services.
For more information
Paula Treutiger
VP, Corporate Communications
Gambro Group
paula.treutiger@gambro.com
Phone: +46 (0)8 613 6599
WebWireID14849
- Contact Information
- Paula Treutiger
- VP, Corporate Communications
- Gambro Group
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.